TW · Healthcare

Lotus Pharmaceutical Co Ltd (1795)

Drug Manufacturers - Specialty & Generic

Lotus Pharmaceutical Co Ltd (1795) is listed on TW in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 1795

P/E ratio

18.00

Lotus Pharmaceutical Co Ltd (1795) — FAQ

What is 1795's P/E ratio?

The price-to-earnings (P/E) ratio for Lotus Pharmaceutical Co Ltd (1795) is 18.00 (data as of 2026-05-23).

Does Lotus Pharmaceutical Co Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Lotus Pharmaceutical Co Ltd (1795). Check the MyAverix Finance app for the latest dividend data.

What sector is Lotus Pharmaceutical Co Ltd in?

Lotus Pharmaceutical Co Ltd (1795) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 1795 listed on?

1795 is listed on TW.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)